Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preclinical Characterization of a Novel Anti-Cancer PD-L1 Inhibitor RPH-120.
Kulikov A, Shipaeva E, Dmitrieva A, Batrak V, Shipunov G, Guy C, Smith J, Zhang R, Zhang M, Duan J, Chestukhin A, Barbashov S, Samsonov M, Lavrovsky Y. Kulikov A, et al. Among authors: lavrovsky y. Front Pharmacol. 2021 Aug 11;12:723038. doi: 10.3389/fphar.2021.723038. eCollection 2021. Front Pharmacol. 2021. PMID: 34456733 Free PMC article.
Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study.
Morozova MA, Lepilkina TA, Rupchev GE, Beniashvily AG, Burminskiy DS, Potanin SS, Bondarenko EV, Kazey VI, Lavrovsky Y, Ivachtchenko AV. Morozova MA, et al. Among authors: lavrovsky y. CNS Spectr. 2014 Aug;19(4):316-23. doi: 10.1017/S1092852913000394. Epub 2013 Jun 17. CNS Spectr. 2014. PMID: 23768250 Clinical Trial.
CXCR4 receptor as a promising target for oncolytic drugs.
Lavrovsky Y, Ivanenkov YA, Balakin KV, Medvedeva DA, Ivachtchenko AV. Lavrovsky Y, et al. Mini Rev Med Chem. 2008 Oct;8(11):1075-87. doi: 10.2174/138955708785909907. Mini Rev Med Chem. 2008. PMID: 18855724 Review.
Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors.
Koryakova AG, Ivanenkov YA, Ryzhova EA, Bulanova EA, Karapetian RN, Mikitas OV, Katrukha EA, Kazey VI, Okun I, Kravchenko DV, Lavrovsky YV, Korzinov OM, Ivachtchenko AV. Koryakova AG, et al. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3661-6. doi: 10.1016/j.bmcl.2007.11.121. Epub 2007 Dec 5. Bioorg Med Chem Lett. 2008. PMID: 18502121
5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial).
Morozova M, Burminskiy D, Rupchev G, Lepilkina T, Potanin S, Beniashvili A, Lavrovsky Y, Vostokova N, Ivaschenko A. Morozova M, et al. Among authors: lavrovsky y. J Clin Psychopharmacol. 2017 Apr;37(2):169-175. doi: 10.1097/JCP.0000000000000673. J Clin Psychopharmacol. 2017. PMID: 28141622 Clinical Trial.
35 results